Skip to main content
. 2015 Nov 14;31(6):937–944. doi: 10.1093/ndt/gfv380

Table 2.

Association of eGFR versus homocysteine with vascular outcomes

Beta (SE) P-value
A. Outcome = TPA
 Unadjusted regression (N = 1967)
  Model 1 (R2 = 0.17)
   eGFR −0.03 (0.002) <0.0001
  Model 2 (R2 = 0.08)
   tHcy 1.24 (0.10) <0.0001
  Model 3 (R2 = 0.18)
   eGFR −0.03 (0.002) <0.0001
   tHcy 0.51 (0.10) <0.0001
 Adjusted regression (N = 1690)
  Model 1 (R2 = 0.44)
   eGFR −0.005 (0.002) 0.006
  Model 2 (R2 = 0.44)
   tHcy 0.26 (0.09) 0.003
  Model 3 (R2 = 0.44)
   eGFR −0.004 (0.002) 0.06
   tHcy 0.20 (0.09) 0.03
B. Outcome = stenosis
 Unadjusted regression (N = 1965)
  Model 1 (R2 = 0.02)
   eGFR −0.17 (0.03) <0.0001
  Model 2 (R2 = 0.01)
   tHcy 5.99 (1.67) 0.0003
  Model 3 (R2 = 0.02)
   eGFR −0.15 (0.03) <0.0001
   tHcy 2.38 (1.86) 0.20
 Adjusted regression (N = 1688)
  Model 1 (R2 = 0.06)
   eGFR −0.08 (0.04) 0.08
  Model 2 (R2 = 0.06)
   tHcy 3.61 (1.88) 0.06
  Model 3 (R2 = 0.06)
   eGFR −0.05 (0.04) 0.23
   tHcy 2.80 (2.00) 0.16

Carotid plaque burden is measured by TPA and total stenosis is measured by the sum of % stenosis in the right and left internal carotid arteries. TPA and tHcy, not eGFR and stenosis, are in log scale due to skewness. Model 1 has eGFR in the model, Model 2 has tHcy in the model and Model 3 has both eGFR and tHcy in the model. Adjusted models are adjusted for age, sex, SBP, smoking (in pack years), LDL, HDL and weight.

HHS Vulnerability Disclosure